Page 98 - TD-3-3
P. 98

Tumor Discovery                                        PTMAP5–hsa-miR-22-3p–KIF2C axis in HCC development



            References                                            UALCAN: An update to the integrated cancer data analysis
                                                                  platform. Neoplasia. 2022;25:18-27.
            1.   World Health Organization.  Cancer Today: Cancer Fact
               Sheets. Available from: https://gco.iarc.who.int/today/en/     doi: 10.1016/j.neo.2022.01.001
               fact-sheets-cancers [Last accessed on 2023 Dec 05].  14.  Sherman  BT,  Hao  M,  Qiu  J,  et al.  DAVID:  A  web  server

            2.   Kulik L, El-Serag HB. Epidemiology and management   for functional enrichment analysis and functional
               of   hepatocellular  carcinoma.  Gastroenterology.   annotation of gene lists (2021 update).  Nucleic Acids Res.
               2019;156(2):477-491.e1.                            2022;50(W1):W216-W221.
               doi: 10.1053/j.gastro.2018.08.065                  doi: 10.1093/nar/gkac194
            3.   EASL Clinical Practice Guidelines: Management of   15.  Li  JH,  Liu  S,  Zhou  H,  Qu  LH,  Yang  JH.  starBase  v2.0:
               hepatocellular carcinoma. J Hepatol. 2018;69(1):182-236.  Decoding miRNA-ceRNA, miRNA-ncRNA and protein-
                                                                  RNA interaction networks from large-scale CLIP-Seq data.
               doi: 10.1016/j.jhep.2018.03.019                    Nucleic Acids Res. 2014;42(Database issue):D92-D97.
            4.   Barletta E, Tinessa V, Daniele B. Screening of hepatocellular      doi: 10.1093/nar/gkt1248
               carcinoma: Role of the alpha-fetoprotein (AFP) and
               ultrasonography. Recenti Prog Med. 2005;96(6):295-299.  16.  Ru B, Wong CN, Tong  Y,  et al. TISIDB: An integrated
                                                                  repository portal for tumor-immune system interactions.
            5.   Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in   Bioinformatics. 2019;35(20):4200-4202.
               cancer biology. Cancer Discov. 2011;1(5):391-407.
                                                                  doi: 10.1093/bioinformatics/btz210
               doi: 10.1158/2159-8290.CD-11-0209
                                                               17.  Zhou JW, Wang H, Sun W, Han NN, Chen L. ASPM is a
            6.   Mighell AJ, Smith NR, Robinson PA, Markham AF.   predictor of overall survival and has therapeutic potential in
               Vertebrate pseudogenes. FEBS Lett. 2000;468(2-3):109-114.  endometrial cancer. Am J Transl Res. 2020;12(5):1942-1953.
               doi: 10.1016/s0014-5793(00)01199-6              18.  Li L, Kong XA, Zang M, et al. Hsa_circ_0003732 promotes
            7.   Ling H, Vincent K, Pichler M,  et al. Junk DNA and the   osteosarcoma cells proliferation via miR-545/CCNA2 axis.
               long non-coding RNA twist in cancer genetics. Oncogene.   Biosci Rep. 2020;40(6):BSR20191552.
               2015;34(39):5003-5011.                             doi: 10.1042/BSR20191552
               doi: 10.1038/onc.2014.456                       19.  Li J, Chen Y, Wang X, Wang C. CDCA2 triggers in vivo and in
            8.   Nakamura-García AK, Espinal-Enríquez J. Pseudogenes in   vitro proliferation of hepatocellular carcinoma by activating
               cancer: State of the art. Cancers (Basel). 2023;15(16):4024.  the AKT/CCND1 signaling. J BUON. 2021;26(3):882-888.
                                                               20.  Liao W, Liu W, Liu X, et al. Upregulation of FAM83D affects
               doi: 10.3390/cancers15164024
                                                                  the proliferation and invasion of hepatocellular carcinoma.
            9.   Meng J, Wei Y, Deng Q, Li L, Li X. Study on the expression   Oncotarget. 2015;6(27):24132-24147.
               of TOP2A in hepatocellular carcinoma and its relationship
               with patient prognosis. Cancer Cell Int. 2022;22(1):29.     doi: 10.18632/oncotarget.4432
               doi: 10.1186/s12935-021-02439-0                 21.  Chen J, Li S, Zhou S,  et al. Kinesin superfamily protein
                                                                  expression and its association with progression and
            10.  Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: Archive   prognosis in hepatocellular carcinoma. J Cancer Res Ther.
               for functional genomics data sets--update. Nucleic Acids Res.   2017;13(4):651-659.
               2013;41(Database issue):D991-D995.
                                                                  doi: 10.4103/jcrt.JCRT_491_17
               doi: 10.1093/nar/gks1193
                                                               22.  Huang P, Gu Y, Guo L, Zou X, Yi L, Wu G. Bioinformatics
            11.  Huang HY, Lin YCD, Cui S,  et  al. miRTarBase update   analysis and screening of potential target genes related to the
               2022:  An  informative  resource  for  experimentally   lung cancer prognosis. Med Princ Pract. 2023.
               validated miRNA-target interactions.  Nucleic Acids Res.
               2022;50(D1):D222-D230.                             doi: 10.1159/000533891
                                                               23.  Guo J, Zhang W, Sun L,  et  al. KIF2C accelerates the
               doi: 10.1093/nar/gkab1079
                                                                  development of non-small cell lung cancer and is suppressed
            12.  Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA:   by miR-186-3p via the AKT-GSK3β-β-catenin pathway. Sci
               A  web server for cancer and normal gene expression   Rep. 2023;13(1):7288.
               profiling and interactive analyses.  Nucleic Acids Res.
               2017;45(W1):W98-W102.                              doi: 10.1038/s41598-023-30073-5
                                                               24.  Huang X, Zhao F, Wu Q,  et al. KIF2C facilitates tumor
               doi: 10.1093/nar/gkx247
                                                                  growth and metastasis in pancreatic ductal adenocarcinoma.
            13.  Chandrashekar DS, Karthikeyan SK, Korla PK,  et al.   Cancers (Basel). 2023;15(5):1502.


            Volume 3 Issue 3 (2024)                         22                                doi: 10.36922/td.2846
   93   94   95   96   97   98   99   100   101   102   103